1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Grants Available for Chicago-Area Home-Based Palliative Care Practices is sponsored by Home Centered Care Institute (HCCI) in collaboration with Elea Institute. Offers grant support to help develop home-based palliative care capabilities for up to 10 home-based palliative care practices in the greater Chicago area. Focuses on improving care and health outcomes, reducing readmissions, and creating new program revenue streams.
Get alerted about grants like this
Get emailed when new opportunities from “Home Centered Care Institute (HCCI) in collaboration with Elea Institute” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Home-based palliative care practices in the greater Chicago area. Confirm the full requirements in the official notice before applying.
Grants Available for Chicago-Area Home-Based Palliative Care Practices is funded by Home Centered Care Institute (HCCI) in collaboration with Elea Institute. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
With Forms J in FY2027, NIH will no longer accept letters of support — the boilerplate endorsements applicants have padded proposals with for decades. Notice NOT-OD-26-094 replaces them with letters of collaboration, aligning NIH with NSF. Here is exactly what changes, what a compliant letter must now contain, who can no longer write one, and how this fits the broader re-engineering of the NIH application package.
Read articleOMB and roughly 40 agencies have proposed the most sweeping overhaul of 2 CFR Part 200 in more than a decade. Political appointees would pre-review notices of funding opportunity and discretionary awards, agencies gain near-unappealable 'national interest' termination authority, and federal funds can no longer support collaborations with covered foreign entities. The rule drew nearly half a million comments and is slated to take effect October 1, 2026. Here is what actually changes, who is exposed, and how to write proposals that survive the new regime.
Read articleARPA-H's new REST program (ARPA-H-SOL-26-159) wants to move sleep diagnosis out of the lab and into the bedroom — and then close the loop with real-time, at-home treatment. It is a 66-month, three-phase Other Transaction effort aimed at a health burden ARPA-H pegs at $400 billion a year. The gating step is deceptively small: a mandatory Solution Summary due August 12, 2026, that decides who ever gets to submit a full proposal. Here is what REST is really asking for, why the two technical areas favor interdisciplinary teams, and how to treat the solution summary as the actual competition.
Read article